Delivery Order SPE2DB25D3201-SPE2DB25FNTKU
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,114.53 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a generic medication, with a period of performance ending on April 30, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This is a $2,559.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of RIFAMPIN 300 MG CAPSULE 60S, with a period of performance through June 30, 2025. This order is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support...
This is a $3,733.98 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of 300 mg RIFAMPIN capsules, with a firm fixed price of $1,230.50 and a completion date of May 19, 2025. The contract is not set aside and represents an individual delivery order, likely drawn from Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
This is a $5,348.56 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Rifampin 150 mg capsules, with a performance period through May 20, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, including the military healthcare system. The company holds a significant...
This is a $1,917.02 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has an ultimate completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania that serves as a critical supplier of medical and pharmaceutical products to federal...
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,621.59 firm fixed-price delivery order contract is for the provision of 4567253390 RIFAMPIN 300 MG CAPSULE 60S, with a performance period extending through February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $2,906.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 60 capsules of 300 mg rifampin. The contract has an ultimate completion date of March 6, 2024 and was awarded on March 5, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,546.79 firm fixed-price delivery order is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a performance period through June 9, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,273.92, is for the delivery of RIFAMPIN 150 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...